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Patients implanted with a cardioverter defibrillator (ICD) who are suffering from refractory angina pectoris could benefit from spinal
cord stimulation (SCS) due to the well-documented pain relieving effect. However, the combined treatment remains controversial.
The aim of the study is to report successful long-term treatment with SCS in five patients implanted with cardioverter defibrillators.
The combined treatments with ICD and thoracic epidural electrical stimulation were used in five patients with refractory angina pec-
toris. During the procedure of the implantation, testing with the maximal tolerable level of stimulation was carried out to exclude
inference with the ICD. The following treatment with SCS has in all cases been successful, with significant pain relief and improved
quality of life. There were no incidences of inappropriate defibrillator shocks. Spinal cord stimulation for refractory angina pectoris can
be performed in patients implanted with cardioverter defibrillators without interference. However, individual testing during implan-
tation or re-programming the devices is mandatory in order to assess optimal safety in each patient.
Introduction
Patients who are suffering from ischaemic heart pain due to coronary artery sclerosis or coronary artery spasm have impaired
health-related quality of life. Further, these patients may have an increased risk for developing malignant ventricular arrhythmias
leading to sudden cardiac death (SCD), since ischaemic heart disease may be a predisposing factor. Ventricular arrhythmia and
SCD in high-risk patient groups can be effectively prevented by an ICD, and the implantation rates in North America and Europe
have significantly risen during the last years due to the implementation of ACC/AHA/ESC guidelines for management of patients
with ventricular arrhythmias and the prevention of SCD from 2006.1
Chest pain may still persist in some patients who are not suitable candidates for coronary bypass grafting or intra-arterial inva-
sive techniques and in maximal available pharmacological therapy. These patients can be described as suffering from refractory
angina pectoris.2 Spinal cord stimulation in patients suffering from chronic refractory angina pectoris have well-documented
and significant long-term pain relief with improved quality of life2 and SCS has become an established pain treatment in these
patients.
An unknown number of patients with a high risk of developing ventricular tachycardia or SCD are also suffering from refractory
angina pectoris. There exist a few case reports describing the combined treatment with SCS and ICD. In 2001, the ESES-Unit at the
Odense University Hospital published the first case report from Europe about the combined treatment of an ICD and an IPG without
interference.3 However, some concerns have been raised about the possible interaction concerning the spinal cord stimulator in
patients already implanted with an ICD, since potential device interaction may cause an inappropriate shock from the ICD.4,5
Our previous experience in the combination of ICD and SCS encouraged us to continue this treatment, and we have been able to
treat further five patients with the combined therapy.
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Table 1 Patient demographics and history
Patient
number
Year of
birth
Sex Previous AMI
(number)
EF NYHA Cardiac
disease since
Previous PCI
(number)
Previous CABG
(number)
1 1958 M 1 20% (2007) II 2000 2 0
2a 1950 F 0 .50% (2008) I 1994 0 0
3 1937 M 1 10% (2009) III 1991 1 1
4 1955 M 2 50% (2004) II 1995 1 1
5 1949 M 2 25% (2009) III 1996 0 2
AMI, acute myocardial infarction; EF, ejection fraction (according to the last measurement); NYHA, New York Heart Association functional classification; PCI,
percutaneous coronary intervention; CABG, coronary artery bypass grafting.
aThe angina pectoris pain in patient number 2 was diagnosed as Syndrome X. The patient has a normal EF and no signs of congestive heart failure.
Published on behalf of the European Society of Cardiology. All rights reserved.& The Author 2010. For permissions please email: journals.permissions@oxfordjournals.org.
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Case reports
Five patients with ICDs were implanted with a thoracic spinal cord stimulator due to refractory angina pectoris. During the implan-
tation, testing with the maximal tolerable level of SCS was made to exclude inference with the ICD. In all cases, the procedure was
monitored by a specialist from the manufacturer of the ICD. The procedure was preformed as described in our previous publication.3
The following treatment with SCS has in all cases been successful with no incidences of inappropriate defibrillator shocks. Data con-
cerning demographic and technological information are listed in Tables 1 and 2.
Discussion
The present five case reports provide further evidence of a safe combined use of SCS and ICD with the mentioned precautions made.
Owing to the combination of the increasing number of patients with refractory angina pectoris and the ongoing implementation of the
guidelines for the management of ventricular arrhythmias and the prevention of SCD, we expect that an increasing number of cardiac
patients will fulfil the indication to the treatment with both devices. To our knowledge, only few single case reports documenting
successful combination between SCS and ICD have been published so far. However, a long-term follow-up study including a larger
group of patients treated with a combined therapy of SCS and ICD is necessary for further documentation of the safety of the treat-
ment. Further precautions to ensure the safety of the combined treatment could be to test if SCS artefacts mask ventricular arrhyth-
mia resulting in inappropriate inhibition of the ICD. This could be done by induced ventricular arrhythmia during active SCS. So far, we
have decided that the intervention would not be of sufficient benefit for the patients.
Conclusion
Spinal cord stimulation for refractory angina pectoris can be performed in patients implanted with cardioverter defibrillators without
adverse events. However, individual testing is mandatory in order to assess optimal safety in each patient.
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Table 2 Device data
Patient
number
SCS implant
year
SCS
model
ICD implant
year
Indication
for ICD
Symptom ICD mode
(ventricular
sensitivity)
ICD fabricate Follow-up
time
(months)
1 2003 A 2003/2009 VT Syncope VVI-ICD (0.3 mV) Guidant/Medtronic 72
2 2004 A 2001/2007 VF/SSS Lipothymia DDD-ICD (0.3 mV) Guidant/Medtronic 60
3 2004 A 2007 CHF Nonea DDD-ICD (0.3 mV) Guidant 24
4 2004 A 2004 VT/VF Chest pain DDD-ICD (0.3 mV) Medtronic 2b
5 2004/2007 A/B 1998 VT/VF Syncope VVI-ICD (0.3 mV) Medtronic 60
SCS, spinal cord stimulation; ICD, implanted cardioverter defibrillator; VT, ventricular tachycardia; VF, ventricular fibrillation; SSS, sick sinus syndrome; CHF, congestive
heart failure; VVI-ICD, single-chamber ICD; DDD-ICD, dual-chamber ICD; A, Medtronic Itrel III; B, Medtronic Synergy; Sensitivity, programmed ventricular sensitivity.
aProphylactic ICD due to chronic heart failure.
bSCS removed after 2 months due to insufficient relief of the chest pain.
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